Site içinde arama yapın

bir ses eklendi Other

2025-11-28 09:49:02 -

Why Recombinant HGH Remains Vital in Treating Adult and Pediatric Conditions

The global recombinant human growth hormone (RHGH) market was valued at approximately USD 1.77 billion in 2024 and is projected to reach around USD 3.89 billion by 2032, representing a strong CAGR of about 10.30% over the forecast period. As treatments for growth hormone deficiency, Turner Syndrome, idiopathic short stature and other indications evolve,...

0 Yorumlar 0 hisse senetleri 497 Views 0 önizleme